AGNELLI, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 21.269
EU - Europa 12.635
AS - Asia 11.553
SA - Sud America 2.331
Continente sconosciuto - Info sul continente non disponibili 1.090
AF - Africa 319
OC - Oceania 15
Totale 49.212
Nazione #
US - Stati Uniti d'America 20.322
SG - Singapore 5.650
UA - Ucraina 2.215
IE - Irlanda 2.159
IT - Italia 1.942
RU - Federazione Russa 1.887
BR - Brasile 1.749
CN - Cina 1.490
HK - Hong Kong 1.303
VN - Vietnam 1.258
SE - Svezia 963
DE - Germania 892
FR - Francia 737
FI - Finlandia 678
GB - Regno Unito 461
CA - Canada 403
KR - Corea 286
IN - India 269
TR - Turchia 244
BD - Bangladesh 215
AR - Argentina 170
IQ - Iraq 129
MX - Messico 128
PL - Polonia 108
AT - Austria 103
CO - Colombia 98
EC - Ecuador 98
PK - Pakistan 95
CR - Costa Rica 83
NL - Olanda 83
ZA - Sudafrica 83
CH - Svizzera 79
VE - Venezuela 76
UZ - Uzbekistan 74
JP - Giappone 70
ES - Italia 64
ID - Indonesia 63
SA - Arabia Saudita 59
CL - Cile 53
BE - Belgio 52
CW - ???statistics.table.value.countryCode.CW??? 47
GT - Guatemala 47
LB - Libano 47
HN - Honduras 46
PH - Filippine 46
SV - El Salvador 45
MA - Marocco 41
TT - Trinidad e Tobago 41
LT - Lituania 38
PR - Porto Rico 38
JM - Giamaica 36
TN - Tunisia 36
CZ - Repubblica Ceca 35
EG - Egitto 35
IL - Israele 34
JO - Giordania 31
GR - Grecia 29
KE - Kenya 29
PY - Paraguay 27
MY - Malesia 25
NI - Nicaragua 24
AE - Emirati Arabi Uniti 20
BO - Bolivia 19
UY - Uruguay 19
EE - Estonia 17
KG - Kirghizistan 16
PE - Perù 16
OM - Oman 14
RO - Romania 14
TH - Thailandia 14
AL - Albania 13
AZ - Azerbaigian 13
GP - Guadalupe 13
PS - Palestinian Territory 13
SC - Seychelles 13
DZ - Algeria 12
KZ - Kazakistan 12
PA - Panama 12
SK - Slovacchia (Repubblica Slovacca) 12
BG - Bulgaria 11
NP - Nepal 11
ET - Etiopia 10
EU - Europa 10
NG - Nigeria 10
DK - Danimarca 9
SY - Repubblica araba siriana 8
BH - Bahrain 7
CI - Costa d'Avorio 7
HR - Croazia 7
AU - Australia 6
DO - Repubblica Dominicana 6
GE - Georgia 6
GY - Guiana 6
KW - Kuwait 6
NZ - Nuova Zelanda 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
AO - Angola 5
LY - Libia 5
Totale 48.083
Città #
Singapore 3.842
Chandler 2.343
Dublin 2.148
San Jose 1.771
Ashburn 1.353
Hong Kong 1.292
San Mateo 1.222
Jacksonville 1.138
Santa Clara 800
Boardman 767
Council Bluffs 712
Dong Ket 681
Altamura 671
Moscow 645
Princeton 582
Medford 581
Lauterbourg 516
Lawrence 502
Des Moines 495
Wilmington 396
Ann Arbor 383
Andover 360
Perugia 359
Beijing 300
Seoul 284
Los Angeles 264
New York 244
Munich 219
Ho Chi Minh City 206
The Dalles 196
São Paulo 175
Saint Petersburg 174
Izmir 146
Hanoi 143
Helsinki 139
Piscataway 135
Dallas 134
Norwalk 116
Rome 96
Shanghai 96
Montreal 93
San Paolo di Civitate 93
Chicago 88
Frankfurt am Main 79
Phoenix 75
Atlanta 74
Brooklyn 71
North Bergen 68
Redmond 67
Turku 66
Tokyo 64
Orem 62
San José 62
Warsaw 60
Nuremberg 59
Houston 58
Rio de Janeiro 53
Brussels 51
Baghdad 49
Chennai 49
Toronto 49
Stockholm 46
Boston 44
Denver 44
Johannesburg 44
Milan 44
Willemstad 44
Ottawa 42
Philadelphia 42
Columbus 41
Lahore 41
London 41
San Francisco 41
Belo Horizonte 40
San Salvador 40
Brasília 39
Charlotte 39
Woodbridge 39
Dearborn 37
Buffalo 36
Falls Church 36
Naples 36
Mexico City 34
Seattle 34
Amsterdam 32
Hefei 32
Manchester 32
Jeddah 30
Redwood City 29
Tashkent 29
Guatemala City 28
Mumbai 28
Vienna 28
Amman 27
Bologna 27
Da Nang 26
New Delhi 26
Ankara 25
Caracas 25
Den Haag 25
Totale 29.389
Nome #
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 157
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 156
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 155
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 152
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 152
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 152
Aspirin for preventing the recurrence of venous thromboembolism. 148
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 146
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 144
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 142
Acute stroke symptoms: Do differences exist between sexes? 140
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 137
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 134
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 134
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 134
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 132
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 131
Epidemiology of cerebral vein and sinus thrombosis. 130
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 130
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 130
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 129
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 127
Early admission to stroke unit influences clinical outcome 126
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 126
Definition of major bleeding: Prognostic classification 126
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 124
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery The @RISTOS Project 124
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 123
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 123
Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months 123
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 121
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 121
Secondary stroke prevention in women. 121
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 120
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 119
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 119
A prospective study on cardiovascular events after acute pulmonary embolism 118
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 118
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. 117
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 117
Cancer-associated ischemic stroke: A retrospective multicentre cohort study 117
The complexity of patients hospitalized in internal medicine wards evaluated by FADOI-COMPLIMED score(s). A hypothetical approach 117
Profilassi della trombosi venosa profonda in neurochirurgia 116
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 116
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 116
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 116
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 116
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 115
A new strategy for anticoagulation: The factor XI inhibitors 115
Acute pulmonary embolism: external validation of an integrated risk stratification model. 115
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 115
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 114
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 114
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 114
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 114
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 113
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 113
Risk factors for adverse short-term outcome in patients with pulmonary embolism 112
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 112
Lacunar stroke syndromes as predictors of lacunar and non-lacunar infarcts on neuroimaging: a hospital-based study 112
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 112
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 111
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 111
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 111
D-dimer for riskstratification in patients with acute pulmonary embolism. 111
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 111
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 111
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 111
ECOGRAFICA TRANS-TORACICA NELLA VALUTAZIONE DEI FLUIDI POLMONARI EXTRAVASCOLARI DOPO CHIRURGIA TORACICA MAGGIORE 111
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 111
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 110
Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. 110
A sudden neurological deficit in a patient with endocarditis. 110
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 110
Risk factors for venous thromboembolism in the elderly: results of the master registry. 110
Cardiac hemangioma of the right atrium: a possible cause of cerebellar stroke. 110
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 110
Clinical skills or high-tech MR in TIA patients: what makes the difference? 110
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 110
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 110
Prevention of venous thromboembolism in surgical patients 109
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 109
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 109
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 109
Gene-drug interaction in stroke. 108
Initial treatment of venous thromboembolism 108
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 108
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 108
Arterite temporale occulta: contributo casistico e revisione della letteratura 107
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis 107
A prospective study on survival in cancer patients with and without venous thromboembolism. 107
[Occult temporal arteritis. Case reports and review of the literature]. 107
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 107
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 106
Isolated monoparesis following stroke 106
Acute pulmonary embolism. 106
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 106
[Prevention of venous thromboembolism in orthopedic surgery and traumatology]. 106
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. 106
Risk Profile of Symptomatic Lacunar Stroke Versus Nonlobar Intracerebral Hemorrhage 106
Totale 11.926
Categoria #
all - tutte 237.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 237.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.396 0 0 0 0 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/20256.653 52 714 151 240 924 326 179 510 1.438 429 1.052 638
2025/202614.241 1.217 868 729 1.822 1.870 1.244 2.582 741 1.472 1.148 350 198
2026/20274.882 281 437 903 2.974 287 0 0 0 0 0 0 0
Totale 49.212